ADAPY

AS OF

Feb 2 closing price

Price

$0.02

Change

-$0.01 (-28.57%)

Capitalization

5.3M

34 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ADAPY

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Adaptimmune Therapeutics (ADAPY) Ownership - Who owns Adaptimmune Therapeutics?

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

ADAPY

Capitalization

5.3M

P/E Ratio

N/A

Risk (Beta)

3.43

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.25%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

5.46M

Shares Outstanding - Current

265M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

Gain YTD

-23.077

View a ticker or compare two or three

Compare

ADAPY

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for ADAPY

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details